This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert S. Stern, MD; Warwick L. Morison, MD; Lawrence A. Thibodeau, PhD; Ruth A. Kleinerman, MPH; John A. Parrish, MD; Daniel E. Geer, Jr; Thomas B. Fitzpatrick, MD

Arch Dermatol. 1979;115(11):1320-1324.

Abstract
In view of theoretical concern that psoralen ultraviolet A radiation (PUVA) therapy might induce a systemic lupus erythematosus-like syndrome, we studied serum antinuclear antibodies (ANAs) in patients with psoriasis who received PUVA and are participating in a five-year prospective study. At 14 centers, 1,023 patients had two or more ANA determinations. When first and last tests were compared, the incidence of positive tests for ANAs was not significantly different (P >.2). In addition, there was no apparent relationship between the frequency of PUVA treatments and the probability of a positive test. Over a two-year period, there is no evidence to indicate that PUVA therapy for psoriasis has resulted in a significantly higher number of positive tests for ANAs within our population.

(Arch Dermatol 115:1320-1324, 1979)

Author Affiliations
From the Department of Dermatology, the Massachusetts General Hospital (Drs Stern, Morison, Parrish, and Fitzpatrick, and Ms Kleinerman); Beth Israel Hospital (Dr Stern); the Center for the Analysis of Health Practices, Harvard School of Public Health (Drs Stern and Thibodeau); and the Department of Computer Medicine, Beth Israel Hospital (Mr Geer), Harvard Medical School, Boston.

Footnotes
Accepted for publication May 14, 1979.

Reprint requests to the Department of Dermatology, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215 (Dr Stern).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ultraviolet therapy in lupus
Millard and Hawk
Lupus 2001;10:185-187.
ABSTRACT  

Long-term Risks of Psoralen and UV-A Therapy for Psoriasis
Farber et al.
Arch Dermatol 1983;119:426-431.
ABSTRACT  

Long-term Continuation of Psoralen and Ultraviolet-A Treatment of Psoriasis
Stern and Melski
Arch Dermatol 1982;118:400-403.
ABSTRACT  

Annual Rate of Psoralen and Ultraviolet-A Treatment of Psoriasis After Initial Clearing
Melski and Stern
Arch Dermatol 1982;118:404-408.
ABSTRACT  

Antinuclear Antibodies and PUVA Photochemotherapy
Kubba et al.
Arch Dermatol 1981;117:474-477.
ABSTRACT